September 15, 2021
Taiho Pharmaceutical said on September 14 that it has submitted a new drug application for its oral heat shock protein (HSP) 90 inhibitor pimitespib in Japan for the treatment of gastrointestinal stromal tumors (GISTs) that have progressed after chemotherapy. Originated...read more